89 results on '"Xia, Ningshao"'
Search Results
2. PB-GPT: An innovative GPT-based model for protein backbone generation
3. A cryptic site in class 5 epitope of SARS-CoV-2 RBD maintains highly conservation across natural isolates
4. System design and clinical validation of intelligent nucleic acid POCT for un SARS-CoV-2 detection within 30 min
5. Stepping forward: T-cell redirecting bispecific antibodies in cancer therapy
6. Wa-VP4* as a candidate rotavirus vaccine induced homologous and heterologous virus neutralizing antibody responses in mice, pigs, and cynomolgus monkeys
7. Therapeutic vaccine-induced plasma cell differentiation is defective in the presence of persistently high HBsAg levels
8. A non-viral DNA delivery system consisting of multifunctional chimeric peptide fused with zinc-finger protein
9. Construction and characterization of an infectious cDNA clone of human rhinovirus A89
10. Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial
11. Risedronate-functionalized manganese-hydroxyapatite amorphous particles: A potent adjuvant for subunit vaccines and cancer immunotherapy
12. Rational design of a cross-type HPV vaccine through immunodominance shift guided by a cross-neutralizing antibody
13. Numerical and experimental investigation on the performance of rapid ultrasonic-assisted nucleic acid extraction based on dispersive two-phase flow
14. Investigating the virulence of coxsackievirus B6 strains and antiviral treatments in a neonatal murine model
15. Micronanoparticled risedronate exhibits potent vaccine adjuvant effects
16. Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
17. Non-overlapping epitopes on the gHgL-gp42 complex for the rational design of a triple-antibody cocktail against EBV infection
18. All-in-one microfluidic chip for 30-min quantitative point-of-care-testing of nucleic acids
19. Targeting herpesvirus entry complex and fusogen glycoproteins with prophylactic and therapeutic agents
20. Precision and correlation of ED50 and endpoint titer method in measuring HPV vaccine immunogenicity
21. Nasal irrigation efficiently attenuates SARS-CoV-2 Omicron infection, transmission and lung injury in the Syrian hamster model
22. Potential of antibody pair targeting conserved antigenic sites in diagnosis of SARS-CoV-2 variants infection
23. Bivalent rotavirus VP4∗ stimulates protective antibodies against common genotypes of human rotaviruses
24. Endodomain truncation of the HIV-1 envelope protein improves the packaging efficiency of pseudoviruses
25. Cell-based reporter assays for measurements of antibody-mediated cellular cytotoxicity and phagocytosis against SARS-CoV-2 spike protein
26. Development of a rapid neutralization assay for the detection of neutralizing antibodies against coxsackievirus B1
27. An encodable multiplex microsphere-phase amplification sensing platform detects SARS-CoV-2 mutations
28. A hand-held, real-time, AI-assisted capillary convection PCR system for point-of-care diagnosis of African swine fever virus
29. Pre-existing maternal IgG antibodies as a protective factor against congenital cytomegalovirus infection: A mother-child prospective cohort study
30. A stepwise docking molecular dynamics approach for simulating antibody recognition with substantial conformational changes
31. Transferable, easy-to-use and room-temperature-storable PCR mixes for microfluidic molecular diagnostics
32. Rapid PCR powered by microfluidics: A quick review under the background of COVID-19 pandemic
33. Capsid destabilization and epitope alterations of human papillomavirus 18 in the presence of thimerosal
34. Epidemiology of anal human papillomavirus infection and high-grade squamous intraepithelial lesions in 29 900 men according to HIV status, sexuality, and age: a collaborative pooled analysis of 64 studies
35. Cryo-EM structures reveal the molecular basis of receptor-initiated coxsackievirus uncoating
36. Current progress and challenges in the design and development of a successful COVID-19 vaccine
37. A novel point-of-care test of respiratory syncytial viral RNA based on cellulose-based purification and convective PCR
38. Room-temperature-storable PCR mixes for SARS-CoV-2 detection
39. DLL4 restores damaged liver by enhancing hBMSC differentiation into cholangiocytes
40. Demonstration of real-time and accelerated stability of hepatitis E vaccine with a combination of different physicochemical and immunochemical methods
41. Liver chimeric mice with tupaia hepatocyte transplantation as an animal model for hepatitis B virus infection and antiviral therapy
42. Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis
43. Intermittent abortive reactivation of Epstein-Barr virus during the progression of nasopharyngeal cancer as indicated by elevated antibody levels
44. Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection
45. Expression and characterization of a novel truncated rotavirus VP4 for the development of a recombinant rotavirus vaccine
46. Characterization of capsid protein (p495) of hepatitis E virus expressed in Escherichia coli and assembling into particles in vitro
47. A Single-Bead-Based, Fully Integrated Microfluidic System for High-Throughput CD4+T Lymphocyte Enumeration
48. Characterization of an Escherichia coli-derived human papillomavirus type 16 and 18 bivalent vaccine
49. Bacterially expressed human papillomavirus type 6 and 11 bivalent vaccine: Characterization, antigenicity and immunogenicity
50. A novel combined vaccine based on monochimeric VLP co-displaying multiple conserved epitopes against enterovirus 71 and varicella-zoster virus
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.